Belgian INAMI/RIZIV updated the List of reimbursable implants and medical devices

New material codes for implantable non-rechargeable neurostimulator, electrodes, and extensions for stimulation of the dorsal root nodes were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in December 2019.

New material codes and related conditions of reimbursement have been implemented for the following devices:

Implantable non-rechargeable neurostimulator, electrodes, and extensions for stimulation of the dorsal root nodes

• Devices will be reimbursed by individual price (tariff determined individually for each brand name) when registered in the Nominative lists 37701, 37801 and 37901
• The following material codes have been applied:
  • 174532 - 174543 “Fully implanted non-rechargeable neurostimulator for stimulation of the dorsal root nodes, including the patient programmer” with the tariff of €9,170;
  • 174554 - 174565 “Fully implanted, non-rechargeable replacement neurostimulator for stimulating the dorsal root glands, including the patient programmer” with the tariff of €9,170;
  • 174576 - 174580 “Fully implanted non-rechargeable replacement neurostimulator, for stimulation of the dorsal root glands, including the patient programmer, in the event of early replacement” with the tariff of €9,170;
  • 174591 - 174602 “All of the implanted electrodes and extensions, for the stimulation of the dorsal root ganglia, for surgical or percutaneous placement, per intervention” with the tariff of €1,090;
  • 174613 - 174624 “Set of implanted replacement electrodes and extensions for stimulation of the dorsal root ganglia, for surgical or percutaneous placement, per intervention” with the tariff of €1,090;
  • 174635 - 174646 “Set of implanted replacement extensions for stimulation of the dorsal root ganglia, for surgical or percutaneous placement, per intervention” with the tariff of €169;
  • 174650 - 174661 “All electrodes and extensions in the event of negative test stimulation for stimulation of the dorsal root ganglia, for surgical or percutaneous placement, per intervention” with the tariff of €1,090;
• There are specific conditions of reimbursement for these technologies, provided in paragraph B-§13 of the List of reimbursable implants and medical devices.

See the updated version of the List of the reimbursable devices in French and Dutch here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.